Cibc World Markets Corp Abb Vie Inc. Transaction History

Cibc World Markets Corp

$13.5 Billion
Q3 2024

A detailed history of Cibc World Markets Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 239,717 shares of ABBV stock, worth $42.1 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

239,717

Previous 230,194 4.14%

Holding current value

$42.1 Million

Previous $39.5 Million 19.9%

% of portfolio

0.35%

Previous 0.26%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $1.56 Million - $1.9 Million	9,523 Added 4.14%	239,717 $47.3 Million
Q2 2024 Aug 12, 2024	BUY	$154.79 - $180.76 $7.65 Million - $8.93 Million	49,404 Added 27.33%	230,194 $39.5 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $7.42 Million - $8.46 Million	-46,448 Reduced 20.44%	180,790 $32.9 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $8.51 Million - $9.58 Million	61,818 Added 37.37%	227,238 $35.2 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $5.52 Million - $6.39 Million	-41,338 Reduced 19.99%	165,420 $24.7 Million
Q2 2023 Aug 04, 2023	BUY	$132.51 - $164.9 $6.64 Million - $8.27 Million	50,128 Added 32.0%	206,758 $27.9 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $7.42 Million - $8.54 Million	-51,282 Reduced 24.67%	156,630 $25 Million
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $21.8 Million - $26.1 Million	157,576 Added 313.05%	207,912 $33.6 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $6.76 Million - $7.75 Million	50,336 New	50,336 $6.76 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $53.3 Million - $67.7 Million	-387,204 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $54.7 Million - $67.9 Million	-414,715 Reduced 51.72%	387,204 $62.8 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $13.2 Million - $16.7 Million	123,171 Added 18.15%	801,919 $109 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $59.2 Million - $67.2 Million	556,116 Added 453.48%	678,748 $73.2 Million
Q2 2021 Aug 10, 2021	SELL	$105.21 - $117.21 $4.81 Million - $5.36 Million	-45,715 Reduced 27.16%	122,632 $13.8 Million
Q1 2021 May 07, 2021	SELL	$102.3 - $112.62 $16.1 Million - $17.7 Million	-156,959 Reduced 48.25%	168,347 $18.2 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $1.78 Million - $2.4 Million	22,122 Added 7.3%	325,306 $34.9 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $17.4 Million - $20.4 Million	-202,767 Reduced 40.08%	303,184 $26.6 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $29.2 Million - $39 Million	397,720 Added 367.47%	505,951 $49.7 Million
Q1 2020 May 12, 2020	SELL	$64.5 - $97.79 $4.3 Million - $6.52 Million	-66,646 Reduced 38.11%	108,231 $8.25 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $25.9 Million - $32.4 Million	-358,672 Reduced 67.22%	174,877 $15.5 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $11.5 Million - $13.9 Million	183,346 Added 52.35%	533,549 $40.4 Million
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $1.08 Million - $1.38 Million	-16,396 Reduced 4.47%	350,203 $25.5 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $9.35 Million - $11 Million	-121,260 Reduced 24.86%	366,599 $29.5 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $10.1 Million - $12.5 Million	-129,715 Reduced 21.0%	487,859 $45 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $57.8 Million - $64.3 Million	-650,349 Reduced 51.29%	617,574 $58.4 Million
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $75.1 Million - $88.8 Million	835,978 Added 193.54%	1,267,923 $117 Million
Q1 2018 May 11, 2018	BUY	$92.01 - $123.21 $7.11 Million - $9.52 Million	77,231 Added 21.77%	431,945 $40.9 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $9.83 Million - $10.8 Million	109,730 Added 44.79%	354,714 $34.3 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $17.1 Million - $21.9 Million	244,984	244,984 $21.8 Million

Others Institutions Holding ABBV

# of Institutions

3,850

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $311B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.

Account

Cibc World Markets Corp Abb Vie Inc. Transaction History